Transient altered mental status and leptomeningeal enhancement associated with pembrolizumab: a case report
Neurol Sci
.
2021 Nov;42(11):4771-4773.
doi: 10.1007/s10072-021-05479-6.
Epub 2021 Jul 19.
Authors
Keng Lam
1
,
Sameer K Kulkarni
2
,
Manya Khrlobyan
3
,
Pamela K Cheng
4
,
Caroline L Fong
5
Affiliations
1
Department of Neurology, Kaiser Permanente, 1505 N Edgemont, 5th Floor, Los Angeles, CA, 90027, USA. keng.lam@kp.org.
2
Department of Hematology and Oncology, Kaiser Permanente, Los Angeles, CA, USA.
3
Department of Neurology, University of Southern California, Los Angeles, CA, USA.
4
Department of Neurology, Kaiser Permanente, 1505 N Edgemont, 5th Floor, Los Angeles, CA, 90027, USA.
5
Department of Radiology, Kaiser Permanente, Los Angeles, CA, USA.
PMID:
34279791
DOI:
10.1007/s10072-021-05479-6
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Antibodies, Monoclonal, Humanized* / adverse effects
Humans
Magnetic Resonance Imaging*
Substances
Antibodies, Monoclonal, Humanized
pembrolizumab